Recruiting studies: Post Ercp Acute Pancreatitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An European Multi-centre Cohort Study for Unravelling Pharmacokinetic and Genetic Factors Underlying Post-ERCP Pancreati
Phase N/A · 1 location(s) · Radboud University Medical Center · NCT05267379 Rectal NSAIDs With/Without PD Stent for PEP Prevention
NA · 15 location(s) · Air Force Military Medical University, China · NCT07117318 Post-ERCP Pancreatitis - Prophylactic Measures Implementation Study (PEP-PROMIS)
Phase N/A · 1 location(s) · Branislav Kuncak · NCT07244432 Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
Phase 3 · 5 location(s) · Johns Hopkins University · NCT05252754 Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis
Phase 4 · 1 location(s) · University of Calgary · NCT06260878

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.